Shandong Boan Biotechnology’s HK$400 Million H Shares Placement

Ashurst has advised UBS AG Hong Kong Branch on the deal.Shandong Boan Biotechnology Co., Ltd. has successfully completed the placing of 38,400,000 new H shares on…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here